|
RFC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53249643478171E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.87279999975499E-07 |
| Normal-vs-Stage2 |
1.760310E-02 |
| Normal-vs-Stage3 |
9.238000E-04 |
| Normal-vs-Stage4 |
5.368000E-02 |
| Stage1-vs-Stage2 |
8.857800E-01 |
| Stage1-vs-Stage3 |
1.031350E-01 |
| Stage1-vs-Stage4 |
7.864800E-01 |
| Stage2-vs-Stage3 |
3.335400E-01 |
| Stage2-vs-Stage4 |
8.845200E-01 |
| Stage3-vs-Stage4 |
5.234200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44199996388039E-09 |
| Normal-vs-AfricanAmerican |
1.14920000005014E-06 |
| Normal-vs-Asian |
6.035600E-01 |
| Caucasian-vs-AfricanAmerican |
2.964800E-01 |
| Caucasian-vs-Asian |
2.238400E-01 |
| AfricanAmerican-vs-Asian |
1.296420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90539994893157E-09 |
| Normal-vs-Female |
1.03720000033114E-07 |
| Male-vs-Female |
2.129400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.584800E-03 |
| Normal-vs-Extreme_Weight |
2.378300E-04 |
| Normal-vs-Obese |
3.78940000045347E-07 |
| Normal-vs-Extreme_Obese |
5.793200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.505400E-01 |
| Normal_Weight-vs-Obese |
1.026760E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.361000E-01 |
| Extreme_Weight-vs-Obese |
4.700200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.469000E-01 |
| Obese-vs-Extreme_Obese |
7.722100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.298110E-03 |
| Normal-vs-Age(41-60Yrs) |
2.22230012170144E-10 |
| Normal-vs-Age(61-80Yrs) |
3.65010000002997E-06 |
| Normal-vs-Age(81-100Yrs) |
4.606100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.780200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.168590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.286040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.066000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.961400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.426600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.40925074229881E-12 |
| Normal-VS-Type2 PRCC |
1.863800E-02 |
| Normal-VS-KIRP CIMP |
3.824000E-02 |
| Normal-VS-Unclassified PRCC |
3.189500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.344000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.479800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.545000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.453970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.663700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.140600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.179580E-02 |
| Normal-vs-N1 |
8.415800E-04 |
| Normal-vs-N2 |
3.048200E-01 |
| N0-vs-N1 |
2.686300E-02 |
| N0-vs-N2 |
9.328800E-01 |
| N1-vs-N2 |
3.472800E-01 |
|
|
